GC
Gilbert & Cook’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.43M | Buy |
7,716
+252
| +3% | +$46.8K | 0.19% | 47 |
|
2025
Q1 | $1.56M | Sell |
7,464
-1,645
| -18% | -$345K | 0.23% | 34 |
|
2024
Q4 | $1.62M | Sell |
9,109
-84
| -0.9% | -$14.9K | 0.23% | 37 |
|
2024
Q3 | $1.82M | Buy |
9,193
+1,132
| +14% | +$224K | 0.25% | 31 |
|
2024
Q2 | $1.38M | Sell |
8,061
-609
| -7% | -$104K | 0.2% | 37 |
|
2024
Q1 | $1.58M | Sell |
8,670
-1,021
| -11% | -$186K | 0.22% | 42 |
|
2023
Q4 | $1.5M | Buy |
9,691
+861
| +10% | +$133K | 0.21% | 36 |
|
2023
Q3 | $1.32M | Buy |
8,830
+452
| +5% | +$67.4K | 0.21% | 39 |
|
2023
Q2 | $1.13M | Buy |
8,378
+318
| +4% | +$42.8K | 0.18% | 42 |
|
2023
Q1 | $1.28M | Buy |
8,060
+65
| +0.8% | +$10.4K | 0.22% | 34 |
|
2022
Q4 | $1.29M | Sell |
7,995
-103
| -1% | -$16.6K | 0.24% | 34 |
|
2022
Q3 | $1.17M | Buy |
8,098
+136
| +2% | +$19.6K | 0.26% | 38 |
|
2022
Q2 | $1.22M | Buy |
7,962
+462
| +6% | +$70.7K | 0.22% | 35 |
|
2022
Q1 | $1.22M | Buy |
7,500
+179
| +2% | +$29K | 0.2% | 39 |
|
2021
Q4 | $991K | Buy |
7,321
+2,303
| +46% | +$312K | 0.16% | 50 |
|
2021
Q3 | $541K | Buy |
5,018
+175
| +4% | +$18.9K | 0.1% | 95 |
|
2021
Q2 | $546K | Buy |
4,843
+96
| +2% | +$10.8K | 0.1% | 86 |
|
2021
Q1 | $514K | Buy |
4,747
+497
| +12% | +$53.8K | 0.1% | 86 |
|
2020
Q4 | $457K | Sell |
4,250
-4,627
| -52% | -$498K | 0.1% | 83 |
|
2020
Q3 | $778K | Buy |
8,877
+434
| +5% | +$38K | 0.18% | 43 |
|
2020
Q2 | $829K | Buy |
8,443
+1,717
| +26% | +$169K | 0.21% | 42 |
|
2020
Q1 | $512K | Buy |
6,726
+935
| +16% | +$71.2K | 0.15% | 49 |
|
2019
Q4 | $513K | Buy |
5,791
+3,054
| +112% | +$271K | 0.13% | 58 |
|
2019
Q3 | $207K | Buy |
+2,737
| New | +$207K | 0.06% | 115 |
|
2018
Q1 | – | Sell |
-2,290
| Closed | -$221K | – | 93 |
|
2017
Q4 | $221K | Buy |
+2,290
| New | +$221K | 0.08% | 81 |
|
2017
Q3 | – | Sell |
-4,601
| Closed | -$333K | – | 85 |
|
2017
Q2 | $333K | Buy |
+4,601
| New | +$333K | 0.12% | 87 |
|